← The Wire
RIGLNasdaq
RIGEL PHARMACEUTICALS INC
Pharmaceutical Preparations · DE · CIK 1034842
Develops and provides novel therapies for hematologic disorders and cancer by targeting critical disease signaling pathways
red 8-K · 90d
$608M
Market cap
$39.04
Last close
+0.9%
1D
+9.3%
5D
284K
Volume
Price · last 39 sessions+32.2%
May 4L $26.04 · H $39.04Jun 29
355
Total filings
Jun 17, 2026
Last filing
12/31
Fiscal year end
DEF 14ADEF 14AApr 3, 2026DEF 14ADEF 14AApr 10, 2025DEF 14ADEF 14AApr 10, 2024DEF 14ADEF 14AApr 14, 2023DEF 14ADEF 14AApr 5, 2022DEF 14ADEF 14AApr 6, 2021DEF 14ADEF 14AApr 1, 2020DEF 14ADEF 14AApr 9, 2019DEF 14ADEF 14AApr 4, 2018DEF 14ADEF 14AMar 29, 2017DEF 14ADEF 14AMar 28, 2016DEF 14ADEF 14AMar 30, 2015DEF 14ADEF 14AApr 8, 2014DEF 14ADEF 14AApr 3, 2013DEF 14ADEF 14AApr 12, 2012DEF 14ADEF 14AApr 4, 2011DEF 14ADEF 14AApr 12, 2010DEF 14ADEF 14AApr 15, 2009DEF 14ADEF 14AApr 8, 2008
Insider Activity
In the 90 days to Feb 20, 2026: 1 sold $145K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 20, 2026 | Moos Walter HDirector | Sell | 4,000 | $36.36 | $145K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance